Interact to see
Advertisement
Advertisement
NRGEX vs SSDZX
NRGEX vs SSDZX Comparison
Open Charts NRGEX vs SSDZX
Neuberger Berman Genesis E
Price$64.16
Change-$0.59 (-0.91%)
VolumeN/A
Net Assets9.11B
DWS Small Cap Growth R6
Price$35.00
Change-$0.08 (-0.23%)
VolumeN/A
Net Assets263.43M
NRGEX vs SSDZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NRGEX has more cash in the bank: 9.11B vs. SSDZX (263M). NRGEX pays higher dividends than SSDZX: NRGEX (0.54) vs SSDZX (0.00). NRGEX was incepted earlier than SSDZX: NRGEX (4 years) vs SSDZX (11 years). SSDZX (0.89) is less costly to investors than NRGEX (0.69). NRGEX is a more actively managed with annual turnover of: 13.00 vs. SSDZX (4.00). NRGEX (0) and SSDZX (0) have matching initial minimum investment requirements. SSDZX annual gain was more profitable for investors over the last year : 2.46 vs. NRGEX (-2.66).
| NRGEX | SSDZX | NRGEX / SSDZX | |
| Total Expense Ratio | 0.03 | 0.89 | 3% |
| Annual Report Gross Expense Ratio | 0.69 | 0.89 | 78% |
| Fund Existence | 4 years | 11 years | - |
| Gain YTD | -2.076 | 4.696 | -44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.11B | 263M | 3,464% |
| Annual Yield % from dividends | 0.54 | 0.00 | - |
| Returns for 1 year | -2.66 | 2.46 | -108% |
| Returns for 3 years | -2.78 | 11.79 | -24% |
| Returns for 5 years | N/A | 14.79 | - |
| Returns for 10 years | N/A | 10.65 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAWZ | 57.83 | 0.07 | +0.12% |
| ProShares Pet Care ETF | |||
| FCBD | 25.59 | 0.01 | +0.05% |
| Frontier Asset Core Bond ETF | |||
| AWF | 11.12 | -0.05 | -0.45% |
| ALLIANCEBERSTEIN GLOBAL HIGH Income FUND | |||
| ISCB | 60.85 | -0.34 | -0.56% |
| iShares Morningstar Small-Cap ETF | |||
| BIS | 14.27 | -0.28 | -1.93% |
| ProShares UltraShort Nasdaq Biotech | |||